Millennium Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
357,677
+350,989
| +5,248% | +$10.1M | 0.01% | 1591 |
|
|
2025
Q1 | $224K | Buy |
+6,688
| New | +$224K | ﹤0.01% | 3598 |
|
|
2024
Q3 | – | Sell |
-43,184
| Closed | -$1.93M | – | 4150 |
|
|
2024
Q2 | $1.93M | Sell |
43,184
-221,827
| -84% | -$9.94M | ﹤0.01% | 2504 |
|
|
2024
Q1 | $12.4M | Sell |
265,011
-108,618
| -29% | -$5.08M | 0.01% | 1364 |
|
|
2023
Q4 | $13.3M | Buy |
373,629
+91,030
| +32% | +$3.24M | 0.01% | 1291 |
|
|
2023
Q3 | $8.4M | Buy |
282,599
+240,071
| +565% | +$7.14M | ﹤0.01% | 1539 |
|
|
2023
Q2 | $766K | Sell |
42,528
-52,279
| -55% | -$942K | ﹤0.01% | 3053 |
|
|
2023
Q1 | $1.52M | Sell |
94,807
-480,681
| -84% | -$7.72M | ﹤0.01% | 2738 |
|
|
2022
Q4 | $10.5M | Buy |
575,488
+253,736
| +79% | +$4.64M | 0.01% | 1521 |
|
|
2022
Q3 | $6.32M | Sell |
321,752
-187,578
| -37% | -$3.68M | ﹤0.01% | 2005 |
|
|
2022
Q2 | $9.5M | Buy |
509,330
+273,170
| +116% | +$5.09M | 0.01% | 1568 |
|
|
2022
Q1 | $5.18M | Buy |
236,160
+203,201
| +617% | +$4.46M | ﹤0.01% | 2247 |
|
|
2021
Q4 | $936K | Buy |
32,959
+20,847
| +172% | +$592K | ﹤0.01% | 3532 |
|
|
2021
Q3 | $255K | Buy |
+12,112
| New | +$255K | ﹤0.01% | 4600 |
|
|
2021
Q1 | – | Sell |
-14,538
| Closed | -$205K | – | 4542 |
|
|
2020
Q4 | $205K | Buy |
+14,538
| New | +$205K | ﹤0.01% | 3704 |
|
|
2020
Q3 | – | Sell |
-113,034
| Closed | -$1.98M | – | 3648 |
|
|
2020
Q2 | $1.98M | Buy |
+113,034
| New | +$1.98M | ﹤0.01% | 2032 |
|
|
2020
Q1 | – | Sell |
-18,041
| Closed | -$453K | – | 3217 |
|
|
2019
Q4 | $453K | Sell |
18,041
-37,108
| -67% | -$932K | ﹤0.01% | 2805 |
|
|
2019
Q3 | $829K | Buy |
+55,149
| New | +$829K | ﹤0.01% | 2431 |
|
|
2019
Q2 | – | Sell |
-8,888
| Closed | -$202K | – | 3515 |
|
|
2019
Q1 | $202K | Buy |
+8,888
| New | +$202K | ﹤0.01% | 3192 |
|